Chizuko Yamamoto
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Biotechnology top 5%
- Pharmacology top 10%
- Co-authors
- Daigo YamamotoShiroh KishiokaTakehiko MaedaMichihiko KuwanoMayumi OnoYuji BasakiMasayoshi KageHajime Hirata
- Topics
- Cancer Treatment and Pharmacology (11 papers)Microbial Metabolism and Applications (5 papers)Pharmacological Effects of Natural Compounds (5 papers)
- Cited by
- BiotechnologyPharmacologyOncology
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Chizuko Yamamoto
46 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 104
- Oncology 322
- Molecular Biology 301
- Pulmonary and Respiratory Medicine 278
- Biotechnology 169
- Pharmacology 166
Countries citing papers authored by Chizuko Yamamoto
This map shows the geographic impact of Chizuko Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chizuko Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chizuko Yamamoto more than expected).
Fields of papers citing papers by Chizuko Yamamoto
This network shows the impact of papers produced by Chizuko Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chizuko Yamamoto. The network helps show where Chizuko Yamamoto may publish in the future.
Co-authorship network of co-authors of Chizuko Yamamoto
This figure shows the co-authorship network connecting the top 25 collaborators of Chizuko Yamamoto. A scholar is included among the top collaborators of Chizuko Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chizuko Yamamoto. Chizuko Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [The Treatment of Olaparib for BRCA Positive-Metastatic Breast Cancer Patient]. | 1 |
| 2 | 20 | |
| 3 | 29 | |
| 4 | 15 | |
| 5 | 22 | |
| 6 | 14 | |
| 7 | Efficacy of meloxicam in combination with preoperative chemotherapy for breast cancer - Japan Breast Cancer Research Network (JBCRN) 02-1 trial. | 6 |
| 8 | 141 | |
| 9 | 11 | |
| 10 | 20 | |
| 11 | 40 | |
| 12 | 69 | |
| 13 | 21 | |
| 14 | 11 | |
| 15 | 22 | |
| 16 | 15 | |
| 17 | 16 | |
| 18 | 49 | |
| 19 | 49 | |
| 20 | 22 |
About Chizuko Yamamoto
Chizuko Yamamoto is a scholar working on Sensory Systems, Oncology and Biotechnology, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Microbial Metabolism and Applications (5 papers) and Pharmacological Effects of Natural Compounds (5 papers). The work is most often cited by research in Biotechnology (169 citations), Pharmacology (136 citations) and Oncology (322 citations). Chizuko Yamamoto has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Daigo Yamamoto, Shiroh Kishioka, Takehiko Maeda, Michihiko Kuwano, Mayumi Ono, Yuji Basaki, Masayoshi Kage, Hajime Hirata, Akihiko Kawahara and Kazutaka Nakashima. Their work appears in journals such as Journal of Clinical Oncology, NeuroImage and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.